Athenex
Athenex is focused on the development and commercialization of therapies for cancer and immunomodulatory diseases.
Launch date
Employees
Market cap
€135m
Enterprise valuation
€237m (Public information from Aug 2023)
Share price
$0.0152 ATNX
Buffalo New York (HQ)
Authorizing premium user...